AL Amyloidosis FAQs | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

AL Amyloidosis FAQs

key information

source: Myeloma UK

year: N/A

summary/abstract:

What is AL amyloidosis?

The term ‘amyloidosis’ is a general term used for a group of conditions where an abnormal protein, called amyloid, accumulates in the tissues. The build-up of amyloid protein is called an ‘amyloid deposit’. Deposits can occur in various organs or tissues and cause problems.

Facts about AL amyloidosis

• Amyloid can build up in the kidneys, heart, liver, spleen, nerves, or digestive system

• Amyloid can affect two or more organs at the same time

• AL amyloidosis does not affect the brain

• AL amyloidosis is a relatively rare condition, with approximately 500 – 600 people diagnosed in the UK each year

Different types of amyloidosis are named according to the type of amyloid protein which is produced. All begin with the initial ‘A’ which stands for amyloidosis. The ‘A’ is followed by one or more other letters, which identify the particular amyloid protein. For example: AL amyloidosis, AA amyloidosis and ATTR amyloidosis.

 

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close